Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease.
Biotechnol Appl Biochem
; 33(2): 85-9, 2001 04.
Article
en En
| MEDLINE
| ID: mdl-11277860
ABSTRACT
Human erythrocytes from ten patients with chronic obstructive pulmonary disease (COPD) were loaded with increasing amounts of dexamethasone 21-phosphate and were re-infused into the original donors. Drug-loaded erythrocytes acted as circulating bioreactors, converting the non-diffusible dexamethasone 21-phosphate into the diffusible dexamethasone. Pharmacokinetic analyses on these patients showed that a single administration of drug-loaded erythrocytes was able to maintain detectable dexamethasone concentrations in blood for up to seven days. This continuous release of dexamethasone was paralleled by the suspension of beta2-agonist and oral corticosteroid treatments by all of the patients. Thus dexamethasone 21-phosphate-loaded erythrocytes are safe carriers for corticosteroid analogues and are a useful alternative to frequent oral or inhaled drugs in elderly patients with COPD.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dexametasona
/
Sistemas de Liberación de Medicamentos
/
Eritrocitos
/
Enfermedades Pulmonares Obstructivas
/
Antiinflamatorios
Límite:
Aged
/
Aged80
/
Humans
/
Middle aged
Idioma:
En
Revista:
Biotechnol Appl Biochem
Asunto de la revista:
BIOQUIMICA
/
BIOTECNOLOGIA
Año:
2001
Tipo del documento:
Article
País de afiliación:
Italia